Virtual reality is the talk of techies all over the world. But will VR find its way into healthcare on anything approaching a meaningful scale?

As trade and travel restrictions slowly loosen up with Cuba, U.S. suppliers of high-end medical equipment probably have a long wait before they have any chance at all to turn the “Pearl of the Antilles” into a hotspot of their market. 

It’s understandable that hospital systems might balk before setting up ordering providers with order-entry clinical decision support (CDS) tools that, in theory, stand to drive imaging referrals outside the system. After all, referrers have been known to get around CDS recommendations they don’t like by simply sending patients elsewhere. 

It’s a good problem to have, but it’s still a problem: There are more PhD students training for careers in neuroscience research than academic institutions can possibly employ. 

Three months ago Rep. Pete Olson (R-Texas) introduced the Medicare Access to Radiology Care Act of 2016. On May 18 a bipartisan companion bill rolled out of the offices of Sens. John Boozman (R-Ark.) and Bob Casey (D-Pa.). If passed, the measures would allow registered radiologist assistants to, essentially, become the PAs of radiology—with their services reimbursed accordingly.

With the NBA Playoffs in full swing, the league is also working to fund research focused on protecting players from injury.

The Patient-Centered Outcomes Research Institute (PCORI) has announced $44.4 million in funding for 21 new clinical effectiveness research studies centered around patient care, according to a press release.

A new research analysis predicts that the market for breast imaging equipment will grow at an estimated CAGR of 12.2 percent and will eclipse $4.6 billion by the year 2020.